Skip to main content

Closed

NRIX: Nurix Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

89thpctl

Volume

0.37×avg

Market Cap

2.41BUSD

P/E Ratio

-6.7TTM

Div Yield

-ann

Nurix Therapeutics, Inc.

NRIXNASDAQ·USD·Closed

Nurix Therapeutics, Inc.

NRIXNASDAQ·USD·Closed

$23.21

−1.57%

$23.21

−$0.37 (1.57%)

52W Range

89thpctl

Volume

0.37×avg

Mkt Cap

2.41BUSD

P/E

-6.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings